This retrospective cohort analysis assessed whether MRI measures of cerebral blood flow (CBF) and white matter hyperintensities (WMH) distinguish cognitively impaired and unimpaired individuals who harbor core Alzheimer's disease (AD) neuropathology—amyloid-beta (A) and tau (T). The study compared regional gray matter CBF and whole-brain WMH volume across three groups defined by PET biomarker status and cognitive diagnosis.
Data were drawn from The Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center collected between 2018 and 2023. Participants (N = 500) underwent 3T MRI, amyloid PET using 11C-Pittsburgh Compound B, tau PET using 18F-MK6240, and neuropsychological assessments. Based on PET results and cognitive status, participants were categorized as:
Linear models were used to compare group differences in regional gray matter CBF and whole-brain WMH volume.
Across the cohort the mean age was 67 years, 68% of participants were female, and 37% were APOE ε4 carriers. These sample characteristics are reported as the overall descriptive profile of the study population.
NDAN participants demonstrated significantly higher CBF than the AD+MCI group in gray matter regions known to be susceptible to early neurofibrillary tangle formation. Specifically, frontal, temporal, and limbic cortical regions showed higher CBF in NDAN relative to AD+MCI (ps < 0.05).
The largest between-group differences in CBF—ranging from 22% to 34%—were observed in the occipital and parietal cortices. The authors note that these regions typically accumulate amyloid early in AD progression but remain largely free of tau pathology until later stages, which aligns with the observed pattern of preserved CBF in cognitively unimpaired A+T+ individuals.
These regional CBF distinctions indicate that NDAN individuals, despite having core AD neuropathology (A+T+), retain higher perfusion in several cortical areas compared with cognitively impaired A+T+ participants.
Whole-brain WMH volume differentiated the AD+MCI group from Controls (p = 0.002), indicating greater WMH burden in cognitively impaired individuals lacking cognitive resilience. However, WMH volume did not significantly distinguish NDAN from AD+MCI (p = 0.16). Thus, while WMH burden is associated with cognitive impairment when comparing AD+MCI to biomarker-negative Controls, it did not account for the preserved cognition observed in the NDAN group in this sample.
The principal interpretation presented is that preserved regional CBF differentiates NDAN from AD+MCI and supports a role for vascular factors in cognitive resilience to core AD pathology. The most pronounced preservation of CBF in NDAN occurred in parietal and occipital cortices—areas that accumulate amyloid early but remain mostly tau-free in the early stages of disease—suggesting regional perfusion may contribute to maintained cognition despite A+T+ status.
This analysis used linear modeling on imaging-derived measures from 3T MRI and PET scans. Detailed model specifications and analytic code were not reported in the summary. All data produced in the study are available upon committee approval via the institutional data request process indicated by the authors (https://wrap.wisc.edu/data-requests-2/). The Health Sciences Institutional Review Board of the University of Wisconsin provided ethical approval for the work, and authors declared that participant consent procedures and reporting guidelines were followed. Competing interests were declared as none.
Note: The source provides these findings and interpretation; details such as full statistical model parameters, covariates, and effect estimates beyond the percentage CBF differences were not reported in the summary and would require consulting the full preprint or data access request.